Volver al ranking

Similares a BE HEARD EXT: Bimekizumab Shows Greater Benefit With Earlier Use in HS

20 vecinos (text_768) · 14 views · HCPLive · Estados Unidos

BE HEARD EXT: Bimekizumab Shows Greater Benefit With Earlier Use in HS

HCPLive

@hcplivenews

14Estados Unidos
17Upadacitinib Shows Strong Safety Profile in Severe Alopecia Areata

HCPLive

@hcplivenews

611Estados Unidos85
5First Oral Therapy for #HidradenitisSuppurativa in Phase 3

HCPLive

@hcplivenews

344Estados Unidos88
8How New Biologics Are Changing #AtopicDermatitis Treatment

HCPLive

@hcplivenews

274Estados Unidos86
7How New Biologics Are Changing #AtopicDermatitis Treatment

HCPLive

@hcplivenews

272Estados Unidos86
4Results from the First Oral Phase 3 Therapy for #HidradenitisSuppurativa

HCPLive

@hcplivenews

210Estados Unidos88
3Why Povorcitinib's JAK1 Mechanism Matters for HS, With Martina Porter, MD

HCPLive

@hcplivenews

172Estados Unidos90
10How Are New Biologics Changing Atopic Dermatitis Treatment?

HCPLive

@hcplivenews

137Estados Unidos86
19How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD

HCPLive

@hcplivenews

109Estados Unidos85
9How Upadacitinib Could Expand Options for Severe Alopecia Areata, With Natasha Mesinkovska, MD, PhD

HCPLive

@hcplivenews

93Estados Unidos86
20What Is Next for OX40 Ligand Inhibition in Atopic Dermatitis?

HCPLive

@hcplivenews

91Estados Unidos85
16What Upadacitinib Could Mean for Younger Patients With Severe Alopecia Areata

HCPLive

@hcplivenews

82Estados Unidos85
1Bimekizumab Data Support Case for Earlier Intervention in HS

HCPLive

@hcplivenews

78Estados Unidos96
12Prior Authorization, Precision Medicine, and Eczema Remission, With Jason Hawkes, MD

HCPLive

@hcplivenews

69Estados Unidos86
2STOP-HS: Povorcitinib Shows Durable Response in HS at Week 54

HCPLive

@hcplivenews

60Estados Unidos90
13Can CSU Patients Achieve True Remission? BTK Inhibitors, Biomarker Barriers, & More | EAC 2026

HCPLive

@hcplivenews

58Estados Unidos86
14Spotting Scarring Alopecia Before It's Too Late

HCPLive

@hcplivenews

42Estados Unidos85
11Discussing Zumilokibart Data in Atopic Dermatitis, With Ruth Ann Vleugels, MD, MPH, MBA

HCPLive

@hcplivenews

30Estados Unidos86
18Emerging Evidence in Atopic Dermatitis Management, With Harrison Nguyen, MD, MBA, MPH

HCPLive

@hcplivenews

23Estados Unidos85
6Discussing Raising HS Awareness and Treatments, With Kiera Booth, MD

HCPLive

@hcplivenews

20Estados Unidos87
15Why Earlier Treatment Matters in Moderate-to-Severe Atopic Dermatitis

ReachMD

@reachmd

6Estados Unidos85